Delivery Order SPE2D021DA002-SPE2D325F332Q
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,983.53 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and performance to be fulfilled in...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $1,219.75 to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two-pack units). This firm fixed-price delivery order, which must be completed by July 25, 2025, represents a routine pharmaceutical supply fulfillment under the agency's medical logistics operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,045.50 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The delivery order is for epinephrine 0.3 mg auto-inject (two-pack units) and does not utilize a set-aside designation. This award is issued under DMS Pharmaceutical Group's significant...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,712.50 on August 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by August 7, 2025. This delivery order is funded by the Defense Logistics Agency through its Medical Supply Chain division and will be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,613.75 for epinephrine 0.3 mg auto-injector (2-pack) by the Defense Logistics Agency's Medical Supply Chain. The contract carries a firm fixed price arrangement with an ultimate completion date of August 21, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,394.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a completion date of June 27, 2024, is for the delivery of epinephrine injection USP 1:1000 automatic injectors to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $2,644.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the delivery of epinephrine auto-injectors with a period of performance through May 3, 2024. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,395.15 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,478.43 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). The contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and is structured as a firm fixed-price delivery order. The place of performance is Conshohocken, Pennsylvania. This award carries no set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,439.50 on August 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, carries no set-aside designation and is performed at the vendor's Park Ridge location. The award is issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F332QDelivery Order
The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This delivery order leverages DMS Pharmaceutical Group's capabilities as a critical supplier within the federal pharmaceutical distribution network, particularly for medical supplies supporting Department of Defense healthcare operations. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The parent contract enables the agency to issue firm fixed-price delivery orders across a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group has consistently demonstrated strength in competing for federal pharmaceutical contracts and has maintained its role as a significant supplier to military health facilities nationwide since its SAM.gov registration in 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/20/25 |